Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Finished Goods (2016 - 2022)

Biomerica's Finished Goods history spans 11 years, with the latest figure at $1.2 million for Q1 2022.

  • On a quarterly basis, Finished Goods rose 152.07% to $1.2 million in Q1 2022 year-over-year; TTM through Feb 2022 was $1.2 million, a 152.07% increase, with the full-year FY2021 number at $617000.0, up 170.61% from a year prior.
  • Finished Goods hit $1.2 million in Q1 2022 for Biomerica, up from $858000.0 in the prior quarter.
  • Over the last five years, Finished Goods for BMRA hit a ceiling of $1.2 million in Q1 2022 and a floor of $147000.0 in Q4 2019.
  • Historically, Finished Goods has averaged $464812.5 across 5 years, with a median of $310500.0 in 2018.
  • Biggest five-year swings in Finished Goods: skyrocketed 535.37% in 2020 and later crashed 55.34% in 2021.
  • Tracing BMRA's Finished Goods over 5 years: stood at $253000.0 in 2018, then tumbled by 41.9% to $147000.0 in 2019, then skyrocketed by 535.37% to $934000.0 in 2020, then fell by 8.14% to $858000.0 in 2021, then surged by 34.85% to $1.2 million in 2022.
  • Business Quant data shows Finished Goods for BMRA at $1.2 million in Q1 2022, $858000.0 in Q4 2021, and $443000.0 in Q3 2021.